Literature DB >> 19701717

Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics.

Tatsushi Mogi1, Kiyoshi Kita.   

Abstract

Gramicidin S and polymyxins are small cationic cyclic peptides and act as potent antibiotics against Gram-negative and Gram-positive bacteria by perturbing integrity of the bacterial membranes. Screening of a natural antibiotics library with bacterial membrane vesicles identified gramicidin S as an inhibitor of cytochrome bd quinol oxidase and an alternative NADH dehydrogenase (NDH-2) and polymyxin B as an inhibitor of NDH-2 and malate: quinone oxidoreductase. Our studies showed that cationic cyclic peptide antibiotics have novel molecular targets in the membrane and interfere ligand binding on the hydrophobic surface of enzymes. Improvement of the toxicity and optimization of the structures and clinical uses are urgently needed for their effective application in combating drug-resistant bacteria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19701717     DOI: 10.1007/s00018-009-0129-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  58 in total

1.  Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity.

Authors:  L H Kondejewski; M Jelokhani-Niaraki; S W Farmer; B Lix; C M Kay; B D Sykes; R E Hancock; R S Hodges
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

2.  Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa.

Authors:  L Zhang; P Dhillon; H Yan; S Farmer; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

3.  Action of polymyxin B on bacterial membranes: morphological changes in the cytoplasm and in the outer membrane of Salmonella typhimurium and Escherichia coli B.

Authors:  P R Schindler; M Teuber
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

4.  Selective and potent in vitro antimalarial activities found in four microbial metabolites.

Authors:  Hideaki Ui; Aki Ishiyama; Hitomi Sekiguchi; Miyuki Namatame; Aki Nishihara; Yoko Takahashi; Kazuro Shiomi; Kazuhiko Otoguro; Satoshi Omura
Journal:  J Antibiot (Tokyo)       Date:  2007-03       Impact factor: 2.649

5.  Recent Advances in the High Resolution Structures of Bacterial Channels: Gramicidin A.

Authors: 
Journal:  J Struct Biol       Date:  1998       Impact factor: 2.867

6.  Biological function of gramicidin: selective inhibition of RNA polymerase.

Authors:  N Sarkar; D Langley; H Paulus
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

7.  Binding of polymyxin B nonapeptide to gram-negative bacteria.

Authors:  M Vaara; P Viljanen
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

8.  Phenotypic and genomic analyses of the Mycobacterium avium complex reveal differences in gastrointestinal invasion and genomic composition.

Authors:  J A McGarvey; L E Bermudez
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

9.  In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.

Authors:  Funda Timurkaynak; Fusun Can; Ozlem Kurt Azap; Müge Demirbilek; Hande Arslan; Sedef Ozbalikçi Karaman
Journal:  Int J Antimicrob Agents       Date:  2006-02-07       Impact factor: 5.283

10.  Biochemical and spectroscopic properties of cyanide-insensitive quinol oxidase from Gluconobacter oxydans.

Authors:  Tatsushi Mogi; Yoshitaka Ano; Tomoko Nakatsuka; Hirohide Toyama; Atsushi Muroi; Hideto Miyoshi; Catharina T Migita; Hideaki Ui; Kazuro Shiomi; Satoshi Omura; Kiyoshi Kita; Kazunobu Matsushita
Journal:  J Biochem       Date:  2009-05-04       Impact factor: 3.387

View more
  33 in total

Review 1.  The cytochrome bd respiratory oxygen reductases.

Authors:  Vitaliy B Borisov; Robert B Gennis; James Hemp; Michael I Verkhovsky
Journal:  Biochim Biophys Acta       Date:  2011-07-01

2.  Complete Genome Sequence Analysis of Brevibacillus laterosporus Bl-zj Reflects its Potential Algicidal Response.

Authors:  Yulei Zhang; Dong Chen; Jian Cai; Ning Zhang; Feng Li; Changling Li; Xianghu Huang
Journal:  Curr Microbiol       Date:  2021-03-02       Impact factor: 2.188

Review 3.  Using backbone-cyclized Cys-rich polypeptides as molecular scaffolds to target protein-protein interactions.

Authors:  Dipankar Chaudhuri; Teshome Aboye; Julio A Camarero
Journal:  Biochem J       Date:  2019-01-11       Impact factor: 3.857

4.  Resistance phenotypes mediated by aminoacyl-phosphatidylglycerol synthases.

Authors:  Wiebke Arendt; Stefanie Hebecker; Sonja Jäger; Manfred Nimtz; Jürgen Moser
Journal:  J Bacteriol       Date:  2012-01-20       Impact factor: 3.490

Review 5.  Antimicrobial peptides produced by Brevibacillus spp.: structure, classification and bioactivity: a mini review.

Authors:  Xu Yang; Ahmed E Yousef
Journal:  World J Microbiol Biotechnol       Date:  2018-03-29       Impact factor: 3.312

6.  Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria.

Authors:  Chao-Dong Qian; Xue-Chang Wu; Yi Teng; Wen-Peng Zhao; Ou Li; Sheng-Guo Fang; Zhao-Hui Huang; Hai-Chun Gao
Journal:  Antimicrob Agents Chemother       Date:  2011-12-19       Impact factor: 5.191

7.  Synergistic effect of membrane-active peptides polymyxin B and gramicidin S on multidrug-resistant strains and biofilms of Pseudomonas aeruginosa.

Authors:  Marina Berditsch; Thomas Jäger; Nikola Strempel; Thomas Schwartz; Jörg Overhage; Anne S Ulrich
Journal:  Antimicrob Agents Chemother       Date:  2015-06-15       Impact factor: 5.191

8.  Use of parallel validation high-throughput screens to reduce false positives and identify novel dengue NS2B-NS3 protease inhibitors.

Authors:  Suzanne M Tomlinson; Stanley J Watowich
Journal:  Antiviral Res       Date:  2011-12-13       Impact factor: 5.970

9.  Using Chemical Probes to Assess the Feasibility of Targeting SecA for Developing Antimicrobial Agents against Gram-Negative Bacteria.

Authors:  Jinshan Jin; Ying-Hsin Hsieh; Jianmei Cui; Krishna Damera; Chaofeng Dai; Arpana S Chaudhary; Hao Zhang; Hsiuchin Yang; Nannan Cao; Chun Jiang; Martti Vaara; Binghe Wang; Phang C Tai
Journal:  ChemMedChem       Date:  2016-10-18       Impact factor: 3.466

10.  Importance of Lipopolysaccharide and Cyclic β-1,2-Glucans in Brucella-Mammalian Infections.

Authors:  Andreas F Haag; Kamila K Myka; Markus F F Arnold; Paola Caro-Hernández; Gail P Ferguson
Journal:  Int J Microbiol       Date:  2010-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.